#United States #Class Action #DJS Law Group #Eastchester #Immutep Limited

Immutep Limited Under Legal Scrutiny for Securities Violations

In a significant development for investors, Immutep Limited, a biopharmaceutical company listed on NASDAQ under the ticker IMMP, is facing a class action lawsuit due to alleged violations of securities laws. Announced by the DJS Law Group, this lawsuit serves as a reminder for shareholders to understand their rights and consider participating in the legal proceedings if they have suffered any losses.

Overview of the Class Action

The lawsuit targets securities law violations under sections §§10(b) and 20(a) of the Securities Exchange Act of 1934, alongside Rule 10b-5. These claims point to misleading statements made by the company regarding its clinical trial results for eftilagimod alfa (often referred to as 'efti'). The relevant class period is defined as being between March 24, 2025, and March 12, 2026.

According to the complaint, during the class period, Immutep assured investors that their TACTI-004 trial was showing strong operational progress. However, contrary to this claim, the company was aware that the trial was unlikely to meet its primary endpoints for efficacy. This discrepancy raises serious concerns about the credibility of Immutep’s public statements and their impact on shareholder trust.

Important Dates and Deadlines

For those considering their options, it’s crucial to note that the deadline for seeking participation in this class action is July 6, 2026. Shareholders who acquired shares during the specified period and experienced financial loss are encouraged to contact DJS Law Group to explore potential lead plaintiff opportunities. It is important to note that becoming a lead plaintiff is not a prerequisite for recovering any losses incurred.

Why Trust DJS Law Group?

DJS Law Group emphasizes its commitment to enhancing investor returns through comprehensive counsel and aggressive legal representation. The firm specializes in securities class actions and corporate governance litigation, catering primarily to some of the world's largest hedge funds and asset managers.

Their expertise positions them uniquely to handle the complexities of this lawsuit, ensuring that clients’ claims are treated with the utmost respect and diligence. Interested shareholders are invited to join the case and seek restitution for their suffered losses.

Your Rights as an Investor

The ramifications of this lawsuit extend beyond just the immediate financial implications. It underscores the importance of corporate accountability and transparency. As an investor, you have the right to receive truthful and accurate information about the companies in which you invest.

If you are a shareholder of Immutep Limited and believe you have been misled by the company's statements, now is the time to act. Contact DJS Law Group for a free consultation to discuss your situation and potential legal actions.

Conclusion

The unfolding situation at Immutep Limited serves as a critical reminder of the challenges faced by investors in volatile markets. Diligence, awareness, and a proactive approach can make a significant difference in safeguarding your financial interests. If you are affected, take the necessary steps to protect your rights and recover potential losses through this class action lawsuit.

For more information, reach out to David J. Schwartz of DJS Law Group, based in Eastchester, NY. Their dedicated team is prepared to assist you during this complex legal process.